We observed no significant reduction of tumor growth, demonstrating that in vivo tumor growth mediated by the STING pathway is dependent on the tumor-immune component of the PDAC microenvironment (Supplemental Figure 6, Q–S). Here, STING1 is linked to neoplasm.